InterCure has acquired 3 companies, including 3 in the last 5 years.
InterCure’s largest acquisition to date was in 2022, when it acquired Cann Pharmaceutical for $35M. The Company’s most targeted sectors include agriculture (67%) and life science (34%).
85 Medinat ha-Yehudim Street,
Herzliya,
4676670
Israel,
972 7 7460 5012
www.intercure.co
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2025-09-19 |
ISHI · Agriculture
Neurim, Israel ISHI is a medical cannabis technology and brand company that delivers immediate access to advanced cultivation technologies. ISHI is based in Neurim, Israel. |
- | Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
